^99m Tc-HMPAO-leucocyte scintigraphy and [18F]FDG-PET/CT for diagnosis and therapy monitoring in eleven patients with skull base osteomyelitis

Clin Otolaryngol. 2020 Jul;45(4):591-594. doi: 10.1111/coa.13528. Epub 2020 Mar 25.

Authors

Pierre-Adrien Vion¹, Benjamin Verillaud², Frédéric Paycha¹, Abdel Benada¹, Ghada El-Deeb^{1

3}, Philippe Herman², Laure Sarda-Mantel¹

Affiliations

¹ AP-HP, Service de Médecine Nucléaire, Hôpital Lariboisière, Paris, France.
² AP-HP, Hôpital Lariboisière, Université de Paris, Paris, France.
³ Radiopharmacie, Hôpital Lariboisière, Paris, France.

PMID: 32163238
DOI: 10.1111/coa.13528

No abstract available

Publication types

Letter

MeSH terms

Aged
Anti-Bacterial Agents / therapeutic use*
Diabetes Complications / diagnostic imaging
Diabetes Complications / drug therapy
Female
Fluorodeoxyglucose F18
Humans
Leukocytes
Male
Osteomyelitis / diagnostic imaging*
Osteomyelitis / drug therapy*
Osteomyelitis / microbiology
Positron Emission Tomography Computed Tomography*
Radionuclide Imaging*
Radiopharmaceuticals
Retrospective Studies
Skull Base*
Technetium Tc 99m Exametazime

Substances

Anti-Bacterial Agents
Radiopharmaceuticals
Fluorodeoxyglucose F18
Technetium Tc 99m Exametazime